Grollman-Glick Professor of Pharmaceutical Sciences recognized for work on use of computers in chemical and pharmaceutical research.

New center strives to help develop generics and patients who need them

M-CERSI receives grant to study how drug ingredients are combined, mixed, or altered to create tailored medication.

The Patient-Driven Values in Healthcare Evaluation Center of Excellence puts the patient first

Bruce Yu, PhD, is one of eight professors from the University of Maryland, Baltimore and the University of Maryland, College Park awarded $150,000 each over three years.

Program aims to teach patient and stakeholder engagement to enrollees with goal of increasing patient-driven research across the country.

Adjustments on detection method, type of trial should make it easier to gain approval of generic injectable iron drugs.

More than 2,500 attend virtual conference on IVRT/IVPT methods and uses to support demonstration of bioequivalence.

Multi-Disciplinary Team of Researchers – Including UMSOP’s Mass Spectrometry Experts – Identify Mechanism of Protection Conferred by Probiotic Supplement

Five-year grant supports research on nanoparticles’ design on inflammatory responses

New two-year postdoctoral fellowship will provide hands-on technical training, unique drug development experiences, and supervised research projects.

Company spun out of University of Maryland School of Pharmacy provides a sophisticated pharmaceutical modeling and simulation platform with upgraded Productivity and Compliance Suites.